Study guide

12.1 Neonatal Glucose, Electrolyte, Endocrine & Metabolic Disorders

RNC-MNN Maternal Newborn Nursing Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 RNC-MNN Credential Overview, Eligibility & Exam Format 1.2 Evidence-Based Nursing Practice, Legal-Ethical Standards & Study Strategies

2 Chapter 1: Pregnancy & Intrapartum Risk Factors

2.1 Pre-existing Maternal Conditions, Gestational Complications & High-Risk Antepartum Factors 2.2 Intrapartum Complications: Labor Abnormalities, Rupture of Membranes & Chorioamnionitis 2.3 Operative Delivery, Anesthesia Effects & Perinatal Trauma

3 Chapter 2: Maternal Postpartum Physical Assessment & Recovery

3.1 Uterine Involution, Fundal Assessment & Lochial Progression 3.2 Perineal Healing, Episiotomy, Lacerations & Cesarean Wound Evaluation 3.3 Cardiopulmonary, Renal, Gastrointestinal & Musculoskeletal Adaptations

4 Chapter 3: Maternal Nursing Care, Psychosocial Health & Education

4.1 Multimodal Pain Management, Early Ambulation & Bladder/Bowel Recovery 4.2 Psychosocial Transition: Rubin's Phases, Family Bonding & Perinatal Mood Screening 4.3 Patient Education, Contraception, Immunizations & POST-BIRTH Warning Signs

5 Chapter 4: Lactation & Infant Feeding

5.1 Breast Anatomy, Lactogenesis & Endocrine Regulation 5.2 Latch Mechanics, Milk Transfer Assessment (LATCH Score) & Feeding Frequency 5.3 Nipple Trauma, Engorgement, Ankyloglossia & Safe Formula Feeding

6 Chapter 5: Normal Newborn Transition & Assessment

6.1 Cardiopulmonary Transition, Thermal Balance & Cold Stress Prevention 6.2 Systematic Head-to-Toe Examination & Normal Physiologic Variations 6.3 Gestational Age Assessment (New Ballard Score) & Primitive Reflexes

7 Chapter 6: Routine Newborn Care, Resuscitation & Screening

7.1 Immediate Post-Birth Care, Vitamin K, Eye Prophylaxis & Umbilical Cord Care 7.2 Universal Screenings: CCHD, Universal Hearing Screen & Metabolic Bloodspots 7.3 Neonatal Resuscitation Program (NRP) 9th Edition Core Algorithm 7.4 AAP Safe Sleep Guidelines, SUID Prevention & Parent Guidance

8 Chapter 7: Postpartum Hemorrhage & Hematologic Disorders

8.1 Postpartum Hemorrhage: Definitions, Risk Factors & The 4 Ts 8.2 Quantitative Blood Loss (QBL), PPH Staging & Pharmacologic/Surgical Protocols 8.3 Postpartum Coagulopathies (DIC, ITP) & Venous Thromboembolism (DVT, PE)

9 Chapter 8: Postpartum Infections, Hypertension & Cardiopulmonary Emergencies

9.1 Preeclampsia, Eclampsia & HELLP Syndrome in the Postpartum Period 9.2 Endometritis, Surgical Site Infections, UTI & Mastitis 9.3 Maternal Sepsis: Recognition, Resuscitation & Source Control 9.4 Postpartum Cardiopulmonary & Neurologic Emergencies

10 Chapter 9: Endocrine, Psychiatric & Substance Use Complications

10.1 Gestational & Pre-existing Diabetes Postpartum & Postpartum Thyroiditis 10.2 Postpartum Depression, Anxiety Disorders & Postpartum Psychosis 10.3 Perinatal Substance Use, Opioid Use Disorder, Withdrawal & Harm Reduction

11 Chapter 10: Newborn Respiratory & Cardiovascular Complications

11.1 Transient Tachypnea (TTN), Respiratory Distress Syndrome (RDS) & Meconium Aspiration (MAS) 11.2 Congenital Heart Defects (Cyanotic vs. Acyanotic) & Postpartum Presentation 11.3 Persistent Pulmonary Hypertension of the Newborn (PPHN) & Apnea/Bradycardia

12 Chapter 11: Newborn Metabolic, Neurologic, Gastrointestinal & Infectious Complications

12.1 Neonatal Glucose, Electrolyte, Endocrine & Metabolic Disorders 12.2 Neonatal Hyperbilirubinemia & Hematologic Complications 12.3 Early-Onset & Late-Onset Neonatal Sepsis, GBS & TORCH Infections 12.4 Neonatal Abstinence Syndrome (NAS/NOWS) & Birth Trauma/Injuries 12.5 Neonatal Neurologic & Gastrointestinal Complications

12.1 Neonatal Glucose, Electrolyte, Endocrine & Metabolic Disorders

Key Takeaways Explain This Topic AI

Screen symptomatic newborns immediately and routinely screen established risk groups such as SGA, LGA, infants of diabetic mothers, and late-preterm infants.

AAP transitional operational thresholds guide action: refeed/recheck asymptomatic at-risk infants below 25 mg/dL at 0–4 hours or below 35 mg/dL at 4–24 hours; persistent low values require IV treatment.

Symptomatic hypoglycemia needs immediate laboratory confirmation without delaying treatment; IV dextrose is appropriate for severe, symptomatic, or feeding/gel-refractory hypoglycemia.

PES targets for persistent/recurrent disease are not interchangeable with AAP operational thresholds for routine transitional screening.

Recurrent hypoglycemia, acidosis, hyperammonemia, unusual odor, or deterioration after a symptom-free interval suggests endocrine or inborn metabolic disease and requires urgent specialist evaluation.

Last updated: September 2026

12.1 Neonatal Glucose, Electrolyte, Endocrine & Metabolic Disorders

Core Focus: A glucose number must be interpreted by age, symptoms, risk, feeding, and whether the problem is transitional or persistent. Stabilize symptomatic infants and recognize when recurrent abnormalities signal endocrine or genetic metabolic disease.

Risk and screening

Screen immediately for jitteriness, tremor, lethargy, poor feeding, hypotonia, apnea, cyanosis, temperature instability, weak/high-pitched cry, or seizure. Routine risk groups include small- or large-for-gestational-age infants, infants of diabetic mothers (IDM), and late-preterm infants. Other indications include significant illness, hypoxia, hypothermia, or medications that affect glucose.

Feed an asymptomatic at-risk newborn early and screen according to age and policy. Bedside meters are least accurate at low concentrations; obtain a laboratory plasma glucose when the result will determine major treatment, but do not delay treatment of a symptomatic or severely low infant.

AAP operational thresholds during transition

For an asymptomatic at-risk infant:

Birth to 4 hours: if glucose is below 25 mg/dL, feed (and use 40% buccal dextrose gel when included in protocol), then recheck in about one hour. Persistent value below 25 requires IV glucose.

4 to 24 hours: if below 35 mg/dL, feed/gel and recheck; persistent value below 35 requires IV glucose.

Continue monitoring until the infant maintains the protocol target through feed–fast cycles. After 24 hours, inability to maintain values above about 45 mg/dL requires continued evaluation.

A symptomatic infant with glucose below 40 mg/dL generally needs immediate IV treatment. Protocols commonly use 10% dextrose 2 mL/kg (200 mg/kg) followed by a glucose infusion, with frequent rechecks. Avoid concentrated peripheral dextrose that injures veins.

Forty-percent dextrose gel is commonly 0.5 mL/kg (200 mg/kg) massaged into the buccal mucosa, followed by feeding and a protocol-timed recheck. It is not squirted into the posterior pharynx and does not replace IV therapy for severe symptoms or failed enteral treatment.

The Pediatric Endocrine Society uses higher treatment targets when persistent/recurrent hypoglycemia is suspected—often >50 mg/dL during the first 48 hours and >60 mg/dL thereafter. Those goals address possible pathologic disease and should not be mislabeled as the AAP's screening thresholds for normal transition.

Infants of diabetic mothers

Maternal hyperglycemia drives fetal hyperinsulinemia. After cord clamping, glucose supply stops while insulin remains high, so the nadir often occurs early. IDM complications also include polycythemia, hypocalcemia, respiratory distress, hypertrophic cardiomyopathy, hyperbilirubinemia, and birth injury when large for gestational age. Feed early, screen glucose on schedule, and assess respiratory, cardiac, hematologic, and calcium-related findings.

Persistent hypoglycemia and critical samples

Concern rises when glucose cannot be maintained despite adequate intake/infusion, requires an unusually high glucose infusion rate, or persists beyond expected transition. Under specialist direction, collect a critical sample during hypoglycemia—glucose, beta-hydroxybutyrate, free fatty acids, insulin/C-peptide, cortisol, growth hormone, lactate, ammonia, acylcarnitine profile, and urine organic acids as appropriate—without delaying stabilization. Hyperinsulinism often produces low ketones and free fatty acids despite low glucose.

Hypocalcemia

Risk is higher with prematurity, IDM status, perinatal stress, maternal hyperparathyroidism, or high phosphate load. Findings overlap with hypoglycemia: jitteriness, poor feeding, apnea, laryngospasm, prolonged QT, or seizure. Measure ionized calcium when possible. Symptomatic significant hypocalcemia may require slow IV calcium gluconate with continuous heart-rate/ECG monitoring and a secure venous line; stop for bradycardia or extravasation. Never give calcium through an umbilical arterial catheter or mix it with bicarbonate in the same line.

Inborn errors, inheritance, and endocrine clues

An infant with a symptom-free interval followed by poor feeding, vomiting, lethargy, tachypnea, seizures, acidosis, hypoglycemia, hyperammonemia, liver dysfunction, or an unusual odor may have an inborn error of metabolism. Stop unsafe protein/galactose/fructose exposure only under the emergency metabolic plan, stabilize glucose and perfusion, collect critical specimens if feasible, and contact a metabolic specialist immediately. A newborn screen is a screen, not proof that symptomatic disease is absent.

Many inborn errors are autosomal recessive, so unaffected parents may have an affected child and recurrence risk can be substantial. G6PD deficiency is X-linked and can cause hemolysis after oxidative stress. Family history, consanguinity, previous unexplained neonatal death, ethnicity/ancestry when clinically relevant, and prenatal findings inform evaluation without replacing testing.

Hyperglycemia and other endocrine emergencies

Hyperglycemia is most common in very preterm or critically ill infants receiving glucose infusion, steroids, catecholamines, or inadequate insulin response. Confirm a high bedside value, review the glucose infusion rate and medications, assess hydration/osmotic diuresis, and treat the underlying stressor. Do not abruptly eliminate needed calories or give insulin without a closely monitored neonatal protocol because rapid shifts can cause hypoglycemia and electrolyte changes.

Congenital adrenal hyperplasia can present after a symptom-free interval with vomiting, weight loss, dehydration, hyponatremia, hyperkalemia, hypoglycemia, and shock; genital appearance varies and does not exclude it. Obtain emergency electrolytes/glucose and endocrine evaluation and begin stress-dose treatment and fluid resuscitation as ordered. Hypothyroidism is usually detected by newborn screening before symptoms; prompt confirmatory testing and levothyroxine protect neurodevelopment. These examples reinforce that screening follow-up is part of treatment and that a sick infant is evaluated before a screening result returns.

Loading diagram... Neonatal Hypoglycemia Stepwise Clinical Pathway